Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: a comparative analysis with peripheral blood and bone marrow.
暂无分享,去创建一个
[1] J. Kurtzberg,et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.
[2] J. Vose,et al. Dendritic cell-based therapy for mantle cell lymphoma. , 2006, International journal of oncology.
[3] Franco Locatelli,et al. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Kurtzberg,et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. , 1990, International journal of cell cloning.
[5] J. Armitage,et al. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. , 1991, Blood.
[6] J. Wagner,et al. Adult umbilical cord blood transplantation: a comprehensive review , 2006, Bone Marrow Transplantation.
[7] J. Dick,et al. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.
[8] Adrian P Gee,et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. , 2005, Blood.
[9] R. Burt,et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. , 2008, JAMA.
[10] D. Soll,et al. Changes in the motility, morphology, and F-actin architecture of human dendritic cells in an in vitro model of dendritic cell development. , 2000, Cell motility and the cytoskeleton.
[11] D. Harris,et al. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. , 2007, Current stem cell research & therapy.
[12] S. Joshi,et al. Cytotoxicity of Cord Blood Derived Her2/neu-specific Cytotoxic T Lymphocytes against Human Breast Cancer in vitro and in vivo , 2004, Breast Cancer Research and Treatment.
[13] F. Sallusto,et al. Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.
[14] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[15] A. Beutler,et al. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma , 2004, Anti-cancer drugs.
[16] G. Kollias,et al. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. , 2003, Immunity.
[17] B. Ludewig,et al. Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma , 2006, Cancer Immunology, Immunotherapy.
[18] J. Huber,et al. Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[19] J. Jackson,et al. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. , 1995, Blood.
[20] H. Ueno,et al. Immune and Clinical Outcomes in Patients with Stage IV Melanoma Vaccinated with Peptide-Pulsed Dendritic Cells Derived From CD34+ Progenitors and Activated with Type I Interferon , 2005, Journal of immunotherapy.
[21] Junbiao Chang,et al. Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. , 2008, Reproductive biomedicine online.
[22] Tianlun Yang,et al. Transplantation of human umbilical cord blood cells for the repair of myocardial infarction. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[23] A. Aguirre,et al. Dendritic cell immunizations alone or combined with low doses of interleukin‐2 induce specific immune responses in melanoma patients , 2005, Clinical and experimental immunology.
[24] E. Gluckman,et al. Cord blood transplantation: state of the art , 2009, Haematologica.
[25] Wei-Chen Lee,et al. Vaccination of Advanced Hepatocellular Carcinoma Patients with Tumor Lysate-Pulsed Dendritic Cells: A Clinical Trial , 2005, Journal of immunotherapy.
[26] D. Harris,et al. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. , 1994, Bone marrow transplantation.
[27] K. Roszek,et al. [Regulation and direction of umbilical cord blood stem cells differentiation and their therapeutic application]. , 2008, Postepy higieny i medycyny doswiadczalnej.
[28] S. Aamdal,et al. Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients , 2005, British Journal of Cancer.
[29] O. Hegre,et al. Dendritic cell/lymphocyte clustering: Morphologic analysis by transmission electron microscopy and distribution of gold‐labeled MHC class II antigens by high‐resolution scanning electron microscopy , 1993, The Anatomical record.
[30] S. Zang,et al. Umbilical cord blood transplantation in adult myeloid leukemia , 2008, Bone Marrow Transplantation.
[31] K. Theilgaard-Mönch,et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts , 2001, Bone Marrow Transplantation.
[32] S. Joshi,et al. Immunotherapy of Human Neuroblastoma Using Umbilical Cord Blood-Derived Effector Cells , 2007, Journal of Neuroimmune Pharmacology.
[33] Clive Wasserfall,et al. Autologous umbilical cord blood infusion for type 1 diabetes. , 2008, Experimental hematology.
[34] C. Verfaillie,et al. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. , 2005, Experimental hematology.
[35] M. Bishop,et al. Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells. , 1998, International journal of oncology.
[36] S. Joshi,et al. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors. , 2002, In vivo.
[37] F. Koning,et al. Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane , 2004, European journal of immunology.
[38] S. Joshi,et al. Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. , 2002, Journal of hematotherapy & stem cell research.
[39] M. Kraus,et al. Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.
[40] U. Creutzig,et al. Stem cells derived from cord blood in transplantation and regenerative medicine. , 2009, Deutsches Arzteblatt international.